Primary sclerosing cholangitis in children

Area of Science:

• Pediatric Gastroenterology
• Hepatology
• Autoimmune Diseases

Background:

• Primary sclerosing cholangitis (PSC) is a chronic inflammatory condition affecting bile ducts, not uncommon in children.
• Its autoimmune pathogenesis is suggested, but the exact mechanism of tissue damage is unknown.
• Clinical presentation is variable, often lacking cholestasis and resembling autoimmune hepatitis, with less frequent association with chronic colitis than in adults.

Purpose of the Study:

• To summarize the key aspects of childhood primary sclerosing cholangitis, including diagnosis, differential diagnosis, and management challenges.
• To highlight the importance of cholangiography for diagnosis, including intrahepatic ducts.
• To differentiate childhood PSC from other conditions, including secondary causes and neonatal sclerosing cholangitis.

Main Methods:

• Review of clinical presentation, diagnostic criteria, and differential diagnoses for childhood PSC.
• Emphasis on the diagnostic role of cholangiography, including intrahepatic and extrahepatic bile ducts.
• Discussion of histological findings for differentiation from autoimmune hepatitis and consideration of secondary causes.

Main Results:

• Childhood PSC presents variably, often without cholestasis, and can mimic autoimmune hepatitis.
• Cholangiography is crucial for diagnosis, with 40% of pediatric cases lacking extrahepatic involvement.
• Histology aids in distinguishing PSC from autoimmune hepatitis; secondary causes like Langerhans histiocytosis, immunodeficiencies, and cystic fibrosis must be considered.

Conclusions:

• Effective treatment for childhood PSC remains undetermined.
• Liver transplantation is necessary for children with advanced disease (biliary cirrhosis, hepatic decompensation).
• Neonatal sclerosing cholangitis, presenting with neonatal cholestasis, has an uncertain pathogenesis distinct from PSC.